The AFF4/NF-κB/MYC (AF4/FMR2 Family Member 4/ Nuclear Factor Kappa B/ Myelocytomatosis oncogene) signaling network plays a vital role in the upregulation of METTL3 in bladder cancer. This evidence concerns the gene MYC and urinary bladder cancer.